WallStreetZenWallStreetZen

NASDAQ: GLSI
Greenwich Lifesciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GLSI

Based on 1 analyst offering 12 month price targets for Greenwich Lifesciences Inc

Min Forecast
$50.00+124.92%
Avg Forecast
$50.00+124.92%
Max Forecast
$50.00+124.92%

Should I buy or sell GLSI stock?

Based on 1 analyst offering ratings for Greenwich Lifesciences Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GLSI's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates GLSI as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their GLSI stock forecasts and price targets.

GLSI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-30

1 of 1

Forecast return on equity

Is GLSI forecast to generate an efficient return?

Company
-417.6%
Industry
-10.22%
Market
131.97%
GLSI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GLSI forecast to generate an efficient return on assets?

Company
-209.5%
Industry
-19.89%
GLSI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GLSI earnings per share forecast

What is GLSI's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.38
Avg 2 year Forecast
-$1.50

GLSI revenue forecast

What is GLSI's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$8.9M

GLSI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLSI$22.23$50.00+124.92%Buy
STTK$4.27$15.80+270.02%Strong Buy
RGNX$6.34$24.50+286.44%Strong Buy
ENTA$11.35$20.00+76.21%Buy
IRD$4.08$11.56+183.24%Strong Buy
View Top Biotech Stocks

Greenwich Lifesciences Stock Forecast FAQ

Is Greenwich Lifesciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GLSI) stock is to Buy GLSI stock.

Out of 1 analyst, 0 (0%) are recommending GLSI as a Strong Buy, 1 (100%) are recommending GLSI as a Buy, 0 (0%) are recommending GLSI as a Hold, 0 (0%) are recommending GLSI as a Sell, and 0 (0%) are recommending GLSI as a Strong Sell.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.

What is GLSI's earnings growth forecast for 2026-2027?

(NASDAQ: GLSI) Greenwich Lifesciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 106.41%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,345.43%.

Greenwich Lifesciences's earnings in 2026 is -$21,756,993.On average, 4 Wall Street analysts forecast GLSI's earnings for 2026 to be -$20,211,892, with the lowest GLSI earnings forecast at -$21,289,273, and the highest GLSI earnings forecast at -$18,802,784.

In 2027, GLSI is forecast to generate -$22,008,505 in earnings, with the lowest earnings forecast at -$21,145,426 and the highest earnings forecast at -$22,655,814.

What is GLSI's revenue growth forecast for 2026-2027?

(NASDAQ: GLSI) Greenwich Lifesciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 22.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.34%.

Greenwich Lifesciences's revenue in 2026 is $0.On average, 4 Wall Street analysts forecast GLSI's revenue for 2026 to be $0, with the lowest GLSI revenue forecast at $0, and the highest GLSI revenue forecast at $0.

In 2027, GLSI is forecast to generate $131,003,006 in revenue, with the lowest revenue forecast at $125,865,634 and the highest revenue forecast at $134,863,375.

What is GLSI's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: GLSI) forecast ROA is -209.5%, which is lower than the forecast US Biotechnology industry average of -19.89%.

What is GLSI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GLSI price target, the average GLSI price target is $50.00, with the highest GLSI stock price forecast at $50.00 and the lowest GLSI stock price forecast at $50.00.

The Wall Street analyst predicted that Greenwich Lifesciences's share price could reach $50.00 by Dec 30, 2026. The average Greenwich Lifesciences stock price prediction forecasts a potential upside of 124.92% from the current GLSI share price of $22.23.

What is GLSI's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: GLSI) Greenwich Lifesciences's current Earnings Per Share (EPS) is -$1.57. On average, analysts forecast that GLSI's EPS will be -$1.38 for 2026, with the lowest EPS forecast at -$1.45, and the highest EPS forecast at -$1.28. In 2027, GLSI's EPS is forecast to hit -$1.50 (min: -$1.44, max: -$1.54).

What is GLSI's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: GLSI) forecast ROE is -417.6%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.